Mice lacking major histocompatibility complex (MHC) antigens were generated by mating P2-micro-
globulin-deficient, and therefore class I-deficient, animals with MHC class II-deficient animals. When housed under sterile conditions, the resulting MHC-deficient mice appear healthy, survive for many months, and breed successfully. Phenotypically, MHC-deficient mice are depleted of CD4+ and CD8+ T cells in peripheral lymphoid organs due to a lack of appropriate restricting elements. In contrast, the B-cell compartment of these animals appears intact, and MHC-deficient mice can mount specific antibody responses when challenged with a T-independent antigen. Spleen cells from MHC-deficient animals are poor stimulators and responders in a mixed lymphocyte reaction. Despite their relatively weak cellular immune responses in vitro, MHC-deficient mice reject allogeneic skin grafts with little delay, and grafts from MHC-deficient animals are rapidly rejected by normal allogeneic recipients. Taken together, these results emphasize the plasticity of the immune system and suggest that MHC-deficient mice may be useful for examiunig compensatory mechanisms in severely immunocompromised animals.
Our understanding of the development and function of cells in the immune system has been aided by the use of mice that carry spontaneously arising mutations (1) . For example, mutations such as nu, scid, xid, and bg have resulted in animals that lack functional populations of B lymphocytes, T lymphocytes, and/or natural killer cells. However, the occurrence ofthese mutant animals is rare, and the nature ofthe genetic defect responsible for the observed phenotypic change is often not known. With the advent of gene targeting in embryonic stem cells, it is now possible to inactivate specific genes in the immune system to examine their function (2, 3) .
One important set of molecules in the immune system is the major histocompatibility complex (MHC) antigens. Gene targeting has been used to generate mutant mice that lack the cell surface expression of MHC class I (4, 5) and class II (6, 7) antigens. These novel strains have been used to reexamine the maturation of individual T-cell populations and their roles in various immune responses. Thus, although several lines of evidence had suggested that MHC molecules are important for the development of mature T lymphocytes, the phenotypic analysis of these mutant animals confirmed that /32-microglobulin (p2m)-deficient, and therefore class I-deficient, mice lack CD8+ cytolytic cells (4, 5) , whereas class II-deficient mice lack CD4+ helper cells (6, 7) . Recently, these mice have been used to define more clearly the role of CD4+ and CD8+ cells in the response to a number of viral and protozoan infections (8) (9) (10) (11) (12) . Moreover, several reports have demonstrated that 832m-deficient cells are highly susceptible to lysis by natural killer cells from MHC matched normal mice (13) (14) (15) , thereby providing evidence for the "missingself' hypothesis.
The availability of mutant mice that, individually, do not express MHC class I or class II molecules provided the opportunity to attempt to create a murine model oftotal MHC deficiency. Given the importance of MHC molecules in the initiation and maintenance ofimmune responses, such MHCdeficient mice might be expected to be severely immunocompromised, if they could be created at all. Indeed, humans who are afflicted with bare lymphocyte syndrome fail to express MHC molecules and die at an early age unless provided with bone marrow transplants (16) . In this report, we present the phenotypic and functional characterization of mice that lack the cell surface expression of MHC class I and class II molecules. Although our results show that MHCdeficient mice do have many of the expected immune deficiencies, they also suggest that there must be compensatory mechanisms to account for the surprising immunocompetence of these animals.
MATERIALS AND METHODS
Mice. The genotypic and phenotypic analyses of P32m-deficient (4) and class II-deficient mice (6) IIDeceased. **To whom reprint requests should be addressed.
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II-specific monoclonal antibodies (mAbs). mAbs were 3-83P (H-2Kb), 28-14-8S (H-2Db), 25-9-17S (I-Ao3b), and 1E9 (I-A,b).
Cells were washed once in Hanks' balanced salt solution, 3% fetal calf serum, and 0.1% sodium azide and then incubated with a fluorescein-conjugated F(ab')2 fragment of goat antibody to mouse IgG (y-chain-specific). Cells were then washed twice again, fixed in 2% paraformaldehyde, and analyzed by flow cytometry. For directly conjugated antibodies, cells were preincubated with purified anti-Fc'yIIR antibody (2.4G2) for 5 min at 4°C. Fluorescein-conjugated anti-CD4 and anti-IgM and phycoerythrin-conjugated anti-CD8 and anti-B220 were from Pharmingen (San Diego).
Immunization and ELISA Analysis. Animals were immunized i.p. with 100 ,ug of trinitrophenol (TNP)-conjugated Ficoll in phosphate-buffered saline. Animals were bled 3 days prior to immunization and 8 and 16 days post-immunization. Serum was prepared and stored at 4°C. TNP-specific antibody responses were measured by coating flat-well microtiter plates overnight at 4°C with TNP-conjugated bovine serum albumin (25 ,ug/ml) in Tris-buffered saline (TBS). After washing twice with TBS, wells were blocked with 2% goat serum in TBS and then washed twice again with TBS. Serial 5-fold dilutions of the mouse sera, ranging from 1:100 to 1:12,500 in blocking serum, were then incubated for 2 hr at room temperature. Plates were washed five times with TBS prior to adding alkaline phosphatase-conjugated goat antimouse isotype-specific antibodies (1:750 in blocking serum; Southern Biotechnology Associates, Birmingham, AL). After seven washes with TBS, the assays were developed with 0.1 M diethanolamine, pH 9.8/0. a gene disruption at the 182m locus were mated to animals carrying a similar mutation in the A'b gene. Southern blot analysis of DNA from mice born of an intercross between animals heterozygous for gene disruptions at both loci revealed that doubly homozygous offspring were present at the expected Mendelian frequency. When housed under specific pathogen-free conditions and provided with sterile food and water, MHC-deficient mice appear healthy.
To confirm that mice homozygous for gene disruptions at both loci do not express MHC molecules, flow cytometry was performed on spleen cells using several class I and class II mAbs. As shown in Fig. 1A , flow cytometry with mAbs for H-2Kb and H-2Db revealed barely detectable staining on spleen cells from MHC-deficient animals. Low levels of class I heavy chain have been shown to be expressed at the cell surface in the absence of 182m protein (18) , and this phenomenon was also observed in the analysis of /2m-deficient mice (4, 19) . Staining with mAbs to either Aab or A'9b failed to reveal specific staining, again consistent with that previously observed with class II-deficient mice (6, 7). Thus, mice homozygous for mutations at the 832m and A'9b loci are essentially devoid of MHC class I and class II molecules.
We next examined the phenotype of T-cell subsets present in the lymphoid organs of MHC-deficient animals. Flow cytometric analysis of thymocytes from MHC-deficient mice using mAbs specific for CD4 and CD8 revealed the presence of normal numbers of double-positive cells, suggesting that MHC molecules are not required for thymocytes to enter the (Fig. 2) . In contrast, there was a virtual absence of single-positive CD4+ and CD8+ cells. Furthermore, these two populations were significantly depleted in the spleens and lymph nodes of MHC-deficient animals. The small number of single-positive cells seen in these peripheral lymphoid organs (1-5%) is similar to that seen for CD8+ cells in ,82m-deficient mice (4, 5) and CD4+ in class II-deficient animals (6, 7). At present, it is unclear whether the small number ofthese CD4+ and/or CD8+ T cells in the periphery is related to the small amounts of free class I heavy chain expressed on the surface of MHC-deficient cells. Although the spleens from MHC-deficient animals are essentially devoid of mature T cells as defined by markers for CD4 and CD8 (Fig. 2) as well as CD3 and ac3 T-cell receptor (data not shown), their cellularity is approximately twice that of littermate controls. When examined for the presence of cells displaying other surface markers, spleens from MHCdeficient animals have normal numbers of natural killer cells and y8 T cells but greatly increased numbers of B cells, macrophages, and granulocytes (data not shown).
Class II-deficient mice have normal numbers of mature B lymphocytes but are unable to mount antibody responses to T-dependent antigens (6, 7) . Flow cytometric analysis of spleen cells from MHC-deficient animals shows that mature B220+ IgM+ B cells also develop normally in an environment devoid of MHC class I and class II molecules (Fig. 3A) . immunization with the T-independent antigen TNP-Ficoll (Fig. 3B ). In addition, B cells from MHC-deficient animals can be induced to proliferate following stimulation with the mitogen lipopolysaccharide (data not shown). Thus, despite their failure to express MHC molecules at the cell surface, the development and function of B cells in MHC-deficient animals appear normal.
To assess the integrity of the cellular immune response in MHC-deficient mice, we next examined the capacity of MHC-deficient cells to serve as responder and stimulator populations in a MLR. As shown in Fig. 4A , normal 129/Sv (H-2 b) spleen cells are induced to proliferate when cultured with allogeneic (H-2d) stimulator cells. In contrast, spleen cells from MHC-deficient 129/Sv mice demonstrate only marginal levels of proliferation to the same allogeneic stimulator cells. This proliferation is completely abolished when the MHC-deficient responding population is pretreated with CD4 mAb plus complement, suggesting that the responding population is contained within, or dependent on, the small numbers of CD4+ cells found in the periphery of MHCdeficient animals. Given that the peripheral lymphoid organs of MHC-deficient mice are significantly depleted of potentially alloreactive T cells (Fig. 2) , it is not unexpected that spleen cells from these mice demonstrate low levels of proliferation when stimulated in a MLR.
When MHC-deficient spleen cells are used as stimulator cells in a MLR (Fig. 4B) Numerous experiments have indicated that either CD4+ or CD8+ T cells can mediate rejection of MHC-disparate skin grafts but that depletion of both T-cell populations leads to prolonged graft survival (20, 21) . Given that MHC-deficient mice are depleted of CD4+ and CD8+ T cells, we expected that they would allow prolonged survival of MHC-disparate grafts. As shown in Table 1 , MHC-deficient mice reject allogeneic skin grafts almost as rapidly as do normal 129/Sv animals (mean survival time of 13.0 days versus 9.5 days). Though it is possible that this rapid rejection is mediated by the residual 1-5% CD4+ and/or CD8+ T cells present in MHC-deficient mice, we believe this to be unlikely given that spleen cells from MHC-deficient animals demonstrate very low levels of proliferation when stimulated with allogeneic cells in vitro (Fig. 4A) 032m-deficient mice used in these studies were on the background of C57BL/6.
Although the above data suggest that the rapid rejection of MHC-deficient skin grafts is immune mediated, the mechanism of this rejection is unclear at present. One potential explanation is the expression of low levels of class I molecules. Whereas MHC-deficient mice do not express detectable levels of class II molecules, they do express very low levels of free class I heavy chain at the cell surface (Fig. 1) . Recently, it has been demonstrated that the conformation of free class I heavy chain is functionally intact, as 832m-deficient target cells can be lysed by alloreactive cytolytic T cells (19) . However, 832m-deficient cells are lysed 50-fold less effi'ciently than MHC class I-expressing cells, suggesting that the ability of the free class I heavy chain to present antigenic peptides is significantly impaired. Thus, it would be remarkable if the low levels of free class I heavy chain expressed by MHC-deficient mice can alone account for the rapid rejection of their skin grafts. Another possibility is that effector cells in the recipient might be primed by indirect recognition of donor antigens on recipient antigen-presenting cells. However, the effector cells generated by such a mechanism would not be expected to recognize donor antigens on cells in the graft as these cells express such low levels of MHC antigens and probably cannot present immunogenic peptides. Thus, although the mechanism by which these grafts are rejected remains to be elucidated, it is possible that rejection of MHC-deficient grafts may involve a noncytolytic T-cell immune response.
Overall, the phenotype of MHC-deficient mice resembles the combination of that seen in 82m-deficient and class TI-deficient mice. In particular, these animals are almost completely devoid of MHC class I and class II molecules and of mature CD4+ and CD8+ T cells. Given these deficiencies, it is not unexpected that spleen cells from MHC-deficient mice exhibit poor cellular immune responses in vitro. When analyzed for their ability to mount immune responses in vivo, however, MHC-deficient mice were found to be surprisingly immunocompetent. Their B-cell compartment appears to develop normally, and antibody responses to T-independent antigens can be elicited. Furthermore, MHC-deficient mice reject allogeneic skin grafts almost as rapidly as do normal MHC-expressing animals. Thus, our results suggest that some compensatory immune responses may not require MHC antigens, and MHC-deficient mice should therefore serve as useful tools for investigating new pathways of immunoreactivity.
